RE: Nuvec3 Oct 2018 12:07
And just to be sure I'm not making the rest up ..From the RNS "The research program will not result in any financial benefit to the Company and the limited costs of the research, which are not expected to exceed £30,000, will be borne by N4 Pharma." - I would pick out 'Not expected to exceed £ 30,000. We will have to take a rain check on that.